Covered Stents in the Management of Aortic Coarctation and Right Ventricular Outflow Tract Obstruction

[1] Bishnoi RN(2015)NuMED Covered Cheatham-Platinum Stent for the treatment or prevention of right ventricular outflow tract conduit disruption during transcatheter pulmonary valve replacement Catheter Cardiovasc Interv 85 421-427

[2] Jones TK(2016)Immediate outcomes of covered stent placement for treatment or prevention of aortic wall injury associated with coarctation of the aorta (COAST II) JACC Cardiovasc Interv 9 484-493

[3] Kreutzer J(2006)Covered Cheatham-platinum stents for aortic coarctation — early and intermediate-term results J Am Coll Cardiol 47 1457-1463

[4] Ringel RE(2010)Covered stents in the management of coarctation of the aorta in the adult: initial results and 1-year angiographic and hemodynamic follow-up Int J Cardiol 140 287-295

[5] Taggart NW(2014)Comparison between covered and bare Cheatham-Platinum stents for endovascular treatment of patients with native post-ductal aortic coarctation immediate and intermediate-term results JACC Cardiovasc Interv 7 416-423

[6] Minahan M(2017)Post-market surveillance to detect adverse events associated with Melody® valve implantation Cardiol Young 27 1090-1097

[7] Cabalka AK(2005)The CP stent - short, long, covered - for the treatment of aortic coarctation, stenosis of pulmonary arteries and caval veins, and Fontan anastomosis in children and adults: an evaluation of 60 stents in 53 patients Heart 91 948-953

[8] Cetta F(2021)Mechanical properties of low-diameter balloon expandable covered stents Catheter Cardiovasc Interv 97 451-458

[9] Usmani K(2019)Use of the Gore Viabahn VBX balloon-expandable endoprosthesis in the congenital heart disease population Catheter Cardiovasc Interv 94 416-421

[10] Ringel RE(2009)First in man use of the Advanta trademark V12 ePTFE-coated stent in aortic coarctation Catheter Cardiovasc Interv 74 101-102

[1] Bishnoi RN(2015)NuMED Covered Cheatham-Platinum Stent for the treatment or prevention of right ventricular outflow tract conduit disruption during transcatheter pulmonary valve replacement Catheter Cardiovasc Interv 85 421-427

[2] Jones TK(2016)Immediate outcomes of covered stent placement for treatment or prevention of aortic wall injury associated with coarctation of the aorta (COAST II) JACC Cardiovasc Interv 9 484-493

[3] Kreutzer J(2006)Covered Cheatham-platinum stents for aortic coarctation — early and intermediate-term results J Am Coll Cardiol 47 1457-1463

[4] Ringel RE(2010)Covered stents in the management of coarctation of the aorta in the adult: initial results and 1-year angiographic and hemodynamic follow-up Int J Cardiol 140 287-295

[5] Taggart NW(2014)Comparison between covered and bare Cheatham-Platinum stents for endovascular treatment of patients with native post-ductal aortic coarctation immediate and intermediate-term results JACC Cardiovasc Interv 7 416-423

[6] Minahan M(2017)Post-market surveillance to detect adverse events associated with Melody® valve implantation Cardiol Young 27 1090-1097

[7] Cabalka AK(2005)The CP stent - short, long, covered - for the treatment of aortic coarctation, stenosis of pulmonary arteries and caval veins, and Fontan anastomosis in children and adults: an evaluation of 60 stents in 53 patients Heart 91 948-953

[8] Cetta F(2021)Mechanical properties of low-diameter balloon expandable covered stents Catheter Cardiovasc Interv 97 451-458

[9] Usmani K(2019)Use of the Gore Viabahn VBX balloon-expandable endoprosthesis in the congenital heart disease population Catheter Cardiovasc Interv 94 416-421

[10] Ringel RE(2009)First in man use of the Advanta trademark V12 ePTFE-coated stent in aortic coarctation Catheter Cardiovasc Interv 74 101-102